BSE Live
Jan 02, 16:01Prev. Close
1397.55
Open Price
1410.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:59Prev. Close
1398.20
Open Price
1403.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1404.00 (103)
| Key Financial Ratios of Ipca Laboratories (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 32.28 | 63.51 | |
| Diluted EPS (Rs.) | 32.28 | 63.51 | |
| Cash EPS (Rs.) | 39.90 | 75.44 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 135.04 | 220.54 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 135.04 | 220.54 | |
| Dividend / Share(Rs.) | 5.50 | 11.00 | |
| Revenue from Operations/Share (Rs.) | 283.24 | 508.98 | |
| PBDIT/Share (Rs.) | 51.59 | 101.24 | |
| PBIT/Share (Rs.) | 43.98 | 89.65 | |
| PBT/Share (Rs.) | 40.62 | 86.41 | |
| Net Profit/Share (Rs.) | 32.28 | 63.51 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 18.21 | 19.89 | |
| PBIT Margin (%) | 15.52 | 17.61 | |
| PBT Margin (%) | 14.34 | 16.97 | |
| Net Profit Margin (%) | 11.39 | 12.47 | |
| Return on Networth / Equity (%) | 23.90 | 28.79 | |
| Return on Capital Employed (%) | 20.59 | 22.51 | |
| Return on Assets (%) | 11.55 | 14.17 | |
| Total Debt/Equity (X) | 0.65 | 0.56 | |
| Asset Turnover Ratio (%) | 101.36 | 113.63 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.19 | 1.68 | |
| Quick Ratio (X) | 0.62 | 0.96 | |
| Inventory Turnover Ratio (X) | 4.07 | 4.24 | |
| Dividend Payout Ratio (NP) (%) | 17.03 | 17.32 | |
| Dividend Payout Ratio (CP) (%) | 13.78 | 14.58 | |
| Earnings Retention Ratio (%) | 82.97 | 82.68 | |
| Cash Earnings Retention Ratio (%) | 86.22 | 85.42 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 968.84 | 969.64 | |
| EV/Net Operating Revenue (X) | 1.37 | 1.52 | |
| EV/EBITDA (X) | 7.51 | 7.66 | |
| MarketCap/Net Operating Revenue (X) | 1.06 | 1.29 | |
| Retention Ratios (%) | 82.96 | 82.67 | |
| Price/BV (X) | 2.23 | 2.97 | |
| Price/Net Operating Revenue | 1.06 | 1.29 | |
| Earnings Yield | 0.11 | 0.10 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher